Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene ...

Treatment with botulinum toxin A appears to improve tear production and stability and relieve symptoms in patients with dry ...

Nearly three-quarters of older adults with advanced cancer value quality of life over extending survival, according to study ...

At two doses, baxdrostat demonstrated significant reduction in mean seated systolic BP vs. placebo at 12 weeks among patients with uncontrolled or treatment-resistant hypertension, AstraZeneca ...

Bayer announced the FDA approved finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, for the ...

Delayed diagnosis of hypertension after initial elevated BP measurement was tied to lower rates of antihypertensive drug ...

A 52-year-old man presented to our orthopedic clinic with an 8-month history of a right distal forearm mass accompanied by ...

Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

Headache trajectories vary for postmenopausal women who use menopausal hormone therapy, according to a poster presented at ...

In this video from Clinical Trials at the Summit, Lejla Vajzovic, MD, FASRS, of Duke Eye Center, discusses tyrosine kinase inhibitors and gene therapy as different approaches for wet age-related ...

Adults taking a high antihistamine dose vs. placebo before endurance exercise training sessions had less improvement in peak ...

A pharmacogenetics score may help physicians predict which patients with acute myeloid leukemia are more likely to respond to ...